S1B-408

S1 Biopharma, Inc. · Phase 2 active Small molecule

At a glance

Generic name	S1B-408
Sponsor	S1 Biopharma, Inc.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study of S1B-408 in Women With Orgasmic Dysfunction (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

S1B-408 CI brief — competitive landscape report
S1B-408 updates RSS · CI watch RSS
S1 Biopharma, Inc. portfolio CI